HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The peak of blood lactate during the first 24h predicts mortality in acute coronary syndrome patients under extracorporeal membrane oxygenation.

AbstractBACKGROUND:
Parameters allowing for outcome discrimination of extracorporeal membrane oxygenation (ECMO) therapy in acute coronary syndromes (ACS) complicated by refractory cardiogenic shock (CS) and/or cardio-respiratory arrest (CA) remain elusive. We aimed at evaluating the potential prognostic roles of blood and procedural parameters associated with 30-day mortality following ECMO.
METHODS AND RESULTS:
A group of 29 patients with ACS complicated by CS and/or CA, who underwent ECMO at a single center, was retrospectively analyzed. Eighteen patients (62%) died at 30-day follow up. "Survivors" and "non-survivors" had similar demographics, clinical and biochemical characteristics at admission, except for blood lactate peak in the first 24h that was increased in non-survivors. Procedural characteristics of percutaneous coronary intervention (PCI) and ECMO were comparable in either group. The peak of blood lactate concentration predicted 30-day mortality independently of age, sex and ECMO duration. The cutoff value, determined by receiver operating characteristic (ROC) curve analysis, was found at 11mmol/l.
CONCLUSIONS:
The peak of serum lactate under ECMO in the first 24h predicted 30-day mortality in patients with ACS complicated with CS and CA.
AuthorsFabio Rigamonti, Fabrizio Montecucco, Filippo Boroli, Florian Rey, Baris Gencer, Mustafa Cikirikcioglu, Stéphane Reverdin, Federico Carbone, Stephane Noble, Marco Roffi, Carlo Banfi, Raphael Giraud
JournalInternational journal of cardiology (Int J Cardiol) Vol. 221 Pg. 741-5 (Oct 15 2016) ISSN: 1874-1754 [Electronic] Netherlands
PMID27428314 (Publication Type: Journal Article)
CopyrightCopyright © 2016 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Biomarkers
  • Lactic Acid
Topics
  • Acute Coronary Syndrome (blood, mortality, therapy)
  • Aged
  • Biomarkers (blood)
  • Extracorporeal Membrane Oxygenation (mortality, trends)
  • Female
  • Follow-Up Studies
  • Humans
  • Lactic Acid (blood)
  • Male
  • Middle Aged
  • Mortality (trends)
  • Predictive Value of Tests
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: